Head-to-head comparison
HealthSource vs NEUVÉ Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
HealthSource sells compounded semaglutide, compounded tirzepatide and a nightly sublingual tirzepatide tablet in all 50 states, charged every four weeks rather than by the calendar month.
$199 per 4 weeks sema · $299 per 4 weeks tirz · Verified August 2026
Marked down on: You pay before the medical intake — the questionnaire link appears only after checkout, and withdrawing once you have filled it in costs you $25–$45 for the provider review
Desk Score
NEUVE Health publishes twelve microdosing products before any intake, injectable and sublingual for both molecules, while three of its own pages disagree on whether the medication is in the price.
From $179/mo sema · From $240/mo tirz · Verified September 2026
Marked down on: Three pages disagree on whether the drug is in the price; one is headed all-in monthly pricing while its own fine print bills medication separately.
HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 76/100 (C) for NEUVÉ Health. NEUVÉ Health still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
HealthSource
84/100
B
NEUVÉ Health
76/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | HealthSource | NEUVÉ Health |
|---|---|---|
| Semaglutide | $199 per 4 weeks$199 every 4 weeks month-to-month (13 charges a year, all doses, compounded) | From $179/moFrom $179/mo (microdose tier, compounded) |
| Tirzepatide | $299 per 4 weeks$299 every 4 weeks month-to-month (13 charges a year, all doses, compounded) | From $240/moFrom $240/mo (microdose tier, compounded) |
| Coverage | All 50 states | All 50 states claimed; members in 40+ |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks. | Anyone who specifically wants a microdose protocol and will ask what the monthly fee covers. |
| Desk Score | 84/100B | 76/100C |
The verdict
Desk pick — HealthSourceHealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 76/100 (C) for NEUVÉ Health. NEUVÉ Health still holds its ground where its strengths line up with yours.
Choose HealthSource if…
Compounded semaglutide or tirzepatide, by weekly injection or as a nightly tablet, in all 50 states from $199 every four weeks.
$199 per 4 weeks sema · $299 per 4 weeks tirz · All 50 states
Choose NEUVÉ Health if…
Anyone who specifically wants a microdose protocol and will ask what the monthly fee covers.
From $179/mo sema · From $240/mo tirz · All 50 states claimed; members in 40+
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: HealthSource · NEUVÉ Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs HealthSource
- CoreAge Rx vs NEUVÉ Health
- Curex vs HealthSource
- Curex vs NEUVÉ Health
- BetterMe Rx vs HealthSource
- Bodybuilding Health+ vs NEUVÉ Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.